Cargando…
Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation
A new method for the simultaneous determination of celecoxib, erlotinib, and its active metabolite desmethyl-erlotinib (OSI-420) in rat plasma, by liquid chromatography/tandem mass spectrometry with positive/negative ion-switching electrospray ionization mode, was developed and validated. Protein pr...
Autores principales: | Thappali, Satheeshmanikandan R. S., Varanasi, Kanthikiran, Veeraraghavan, Sridhar, Arla, Rambabu, Chennupati, Sandhya, Rajamanickam, Madheswaran, Vakkalanka, Swaroop, Khagga, Mukkanti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447620/ https://www.ncbi.nlm.nih.gov/pubmed/23008811 http://dx.doi.org/10.3797/scipharm.1205-09 |
Ejemplares similares
-
Disposition of Erlotinib and Its Metabolite OSI420 in a Patient with High Bilirubin Levels
por: Czejka, M., et al.
Publicado: (2013) -
Simultaneous Quantification of Baricitinib and Methotrexate in Rat Plasma by LC-MS/MS: Application to a Pharmacokinetic Study
por: Veeraraghavan, Sridhar, et al.
Publicado: (2016) -
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
por: Townsley, C A, et al.
Publicado: (2006) -
Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer
por: Ciuleanu, Tudor-Eliade, et al.
Publicado: (2017) -
Efficacy of erlotinib and celecoxib for patients with advanced non-small cell lung cancer: A retrospective study
por: Jin, Yi-Hua, et al.
Publicado: (2019)